ENOB News and Press, Enochian Biosciences Inc. From 07/31/22

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Enochian To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - July 31, 2022) - Faruqi & Faruqi, LLP, a leading national securities law firm, i...

NEW YORK, NY / ACCESSWIRE / July 27, 2022 / Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Enochian Biosciences, Inc. ("Enochian" or the "Company") (NASDAQ:ENOB) and reminds investors of the September 26, 2022 deadline to seek the ...

LOS ANGELES, July 25, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB)—Today, Enochian BioSciences (the Company) announced that Dr. Richard (Rich) Whitley, M.D., of the University of Alabama at Birmingham (UAB), will become the Company’s Senior Scientific Advisor. A Distinguished Profe...

The law firm of Kirby McInerney LLP is investigating potential claims against Enochian Biosciences, Inc. (“Enochian” or the “Company”) (NASDAQ: ENOB ). The investigation concerns whether Enochian has violated the federal securities laws and/or engaged...

Gainers: Alpha Tau Medical ( DRTS ) +42% . Precigen ( PGEN ) +20% . Amylyx Pharmaceuticals ( AMLX ) +18% . bluebird bio ( BLUE ) +13% . Talaris Therapeutics ( TALS ) +11% . Losers: Revelation Biosciences ( REVB ...

After an internal review of its scientific data, Enochian BioSciences ( NASDAQ: ENOB ) has discovered that a former scientific advisor had altered and falsified two sets of animal data before the company's scientists could review it. "One data set was for an inhaled COVID-...

LOS ANGELES, July 01, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB)—In recent days, Enochian BioSciences (the Company) has conducted a rigorous internal review of scientific data to give partners and investors a clear understanding of the Company’s pipelines. The results of th...

San Francisco, California--(Newsfile Corp. - June 16, 2022) - Hagens Berman urges Enochian Biosciences, Inc. (NASDAQ: ENOB) investors with significant losses to submit your transactions now . The firm is investigating possible securities law violations. Visit: www.hbsslaw.com/investor...

San Francisco, California--(Newsfile Corp. - June 6, 2022) - Hagens Berman urges Enochian Biosciences, Inc. (NASDAQ: ENOB) investors with significant losses to submit your transactions now . The firm is investigating possible securities law violations. Visit: www.hbsslaw.com/investor-fr...

NEW YORK, NY / ACCESSWIRE / June 1, 2022 / Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Enochian Biosciences, Inc. ("Enochian" or the "Company") (NASDAQ:ENOB). If you suffered losses exceeding $50,000 investing in Enochian stoc...